logo
16:01 Mar 06

Concord Drugs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
75.00
+1.98 (+2.71%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Concord Drugs Ltd. Financials

Concord Drugs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
75.00
+1.98 (+2.71%)
16:01 Mar 06
Quality
image/svg+xml

50/100
Medium Financial Strength

Valuation
image/svg+xml

48/100
Mid Valuation

Technical

48/100
Technically Neutral

Strength

3

Weakness

7

Opportunity

0

Threats

0

0.98 %

ROE %

0.51 %

ROA %

0.00

EPS

34.11

BVPS

0.74 %

Net Profit Margin

Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
52.08 44.92 45.24 51.25
Operating Expenses +
47.5 40.87 41.11 47.18
Raw Material
41.16 31.1 35.81 41.6
Increase Decrease in Cost
-0.16 2.16 -0.58 -0.17
Other Manufacturing Expense
0 0 0 0
Employee Cost
4.92 6.08 4.63 4.46
Miscellaneous Expenses
1.58 1.53 1.25 1.29
Operating Profit
4.58 4.05 4.13 4.07
Other Income
0.01 0.01 0.01 0.02
Depreciation
1.63 1.56 1.43 1.4
Interest
1.71 1.87 2.03 1.93
Profit before tax and exceptio..
1.25 0.63 0.69 0.76
Exceptional Items
0 0 0 0
PBT
1.25 0.63 0.69 0.76
Provision for Taxation
0.26 0.16 0.36 0.22
Net Profit
0.99 0.47 0.34 0.57
NET Profit after MI
0.99 0.47 0.34 0.57
EPS
1.06 0.47 0.34 0.51
Operating Profit Margin (%)
8.79 9.02 9.13 7.94
Net Profit Margin (%)
1.9 1.05 0.75 1.11

Concord Drugs Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 54.40 54.40 54.40 54.40 54.40 54.40
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 45.60 45.60 45.60 45.60 45.60 45.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: